BLAIR SCHREPEL: Open Payments
NPI 1770914327 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 38 payments from 11 companies in 2025. Trend: 2023 $1,233 · 2024 $691 · 2025 $731
Food & beverage: $725Education: $7
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $191 |
| UCB, Inc. | 8 | $149 |
| Incyte Corporation | 3 | $67 |
| Janssen Biotech, Inc. | 2 | $62 |
| Lilly USA, LLC | 3 | $58 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| LEO Pharma Inc. | 1 | $29 |
Products named: DUPIXENT, Bimzelx, OPZELURA, TREMFYA, Zoryve, SKYRIZI, NEMLUVIO, TALTZ.
Industry payments across GA — which companies pay providers there.
